{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:44:44Z","timestamp":1790703884535,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.blre.2026.101433","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:08:27Z","timestamp":1789139307000},"page":"101433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neonatal antiphospholipid syndrome\u2013associated thrombosis: Diagnostic pitfalls and therapeutic frontiers"],"prefix":"10.1016","author":[{"given":"Evdokia","family":"Tzatzadaki-Amantou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Lianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas G.","family":"Tsantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Batsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Mougiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Iliodromiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Boutsikou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Tsantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Iacovidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozeta","family":"Sokou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.blre.2026.101433_bb0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.blre.2026.101433_bb0010","series-title":"Primer on the rheumatic diseases","author":"Klippel","year":"2008"},{"issue":"5","key":"10.1016\/j.blre.2026.101433_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1191\/0961203306lu2295cr","article-title":"Neonatal antiphospholipid syndrome","volume":"15","author":"Soares Rolim","year":"2006","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-009-0010-8","article-title":"Neonatal effects of maternal antiphospholipid syndrome","volume":"11","author":"Tincani","year":"2009","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/hematology.2019000073","article-title":"Is there a role for immunosuppression in antiphospholipid syndrome?","volume":"2019","author":"Sevim","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.blre.2026.101433_bb0030","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/0961203307079039","article-title":"Infant perinatal thrombosis and antiphospholipid antibodies: a review","volume":"16","author":"Boffa","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.blre.2026.101433_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/672603","article-title":"Clinical, laboratory, and therapeutic analyses of 21 patients with neonatal thrombosis and antiphospholipid antibodies: a literature review","volume":"2014","author":"Peixoto","year":"2014","journal-title":"J Immunol Res"},{"issue":"Suppl1","key":"10.1016\/j.blre.2026.101433_bb0040","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5152\/eurjrheum.2019.19160","article-title":"Pediatric antiphospholipid syndrome","volume":"7","author":"Madison","year":"2020","journal-title":"Eur J Rheumatol"},{"issue":"10","key":"10.1016\/j.blre.2026.101433_bb0045","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0961203314531842","article-title":"Antiphospholipid antibodies in neonates with stroke\u2014a unique entity or variant of antiphospholipid syndrome?","volume":"23","author":"Berkun","year":"2014","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-025-09605-w","article-title":"A case of atypical infantile de novo antiphospholipid syndrome presenting with neonatal ischemic stroke without any triggering risk factors as a \u201csecond hit\u201d and review of the literature","volume":"73","author":"Bor","year":"2025","journal-title":"Immunol Res"},{"issue":"4","key":"10.1016\/j.blre.2026.101433_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102895","article-title":"Neonatal intracardiac thrombosis secondary to transplacental transfer of maternal antiphospholipid antibodies-a case report and review of the literature","volume":"9","author":"Girgulis","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101433_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.596386","article-title":"Case report: infantile ischemic stroke and antiphospholipid antibodies, description of four cases","volume":"8","author":"Giani","year":"2020","journal-title":"Front Pediatr"},{"issue":"10","key":"10.1016\/j.blre.2026.101433_bb0065","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1515\/cclm-2016-0931","article-title":"Reference ranges of thromboelastometry in healthy full-term and pre-term neonates","volume":"55","author":"Sokou","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.blre.2026.101433_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321405","article-title":"Beyond antibodies: beta-2 glycoprotein I as the unsung guardian of pregnancy","volume":"20","author":"Yagi","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/antib15010014","article-title":"Transplacental antibody transfer: mechanisms, pregnancy-related disruptions, and emerging experimental models","volume":"15","author":"Li","year":"2026","journal-title":"Antibodies"},{"key":"10.1016\/j.blre.2026.101433_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006451","article-title":"Neonatal stroke associated with de novo antiphospholipid antibody and homozygous 1298C\/C methylenetetrahydrofolate reductase mutation","volume":"2012","author":"Rego Sousa","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/0961203320967418","article-title":"Portal vein thrombosis, livedo reticularis, polymicrobial sepsis and high antiphospholipid antibody titers in a newborn: A clinicopathological conference of antiphospholipid-associated neonatal syndrome","volume":"30","author":"Chaudhary","year":"2021","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.blre.2026.101433_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semarthrit.2014.04.003","article-title":"De novo neonatal antiphospholipid syndrome: a case report and review of the literature","volume":"44","author":"Gordon","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.blre.2026.101433_bb0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-019-0392-8","article-title":"The repertoire of maternal anti-viral antibodies in human newborns","volume":"25","author":"Pou","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.blre.2026.101433_bb0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00919271","article-title":"Half-life of the maternal IgG1 allotype in infants","volume":"13","author":"Sarvas","year":"1993","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101986","article-title":"Antiphospholipid syndrome in children","volume":"38","author":"Zajc Avramovic","year":"2024","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.blre.2026.101433_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2026.102805","article-title":"Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection","volume":"101","author":"Borghi","year":"2026","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"10.1016\/j.blre.2026.101433_bb0115","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/annrheumdis-2016-211001","article-title":"European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.blre.2026.101433_bb0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2005.045443","article-title":"Infectious origin of the antiphospholipid syndrome","volume":"65","author":"Shoenfeld","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.blre.2026.101433_bb0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5499\/wjr.v5.i2.59","article-title":"Pathogenetic mechanisms of antiphospholipid antibody production in antiphospholipid syndrome","volume":"5","author":"Willis","year":"2015","journal-title":"World J Rheumatol"},{"key":"10.1016\/j.blre.2026.101433_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109714","article-title":"Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps","volume":"255","author":"Kme\u0165ov\u00e1","year":"2023","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.blre.2026.101433_bb0140","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: A newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"Si","key":"10.1016\/j.blre.2026.101433_bb0145","doi-asserted-by":"crossref","first-page":"Si4","DOI":"10.1093\/rheumatology\/kead603","article-title":"Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?","volume":"63","author":"Raschi","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.blre.2026.101433_bb0150","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1177\/0883073811435238","article-title":"A case of infantile de novo primary antiphospholipid syndrome revealed by a neonatal arterial ischemic stroke","volume":"27","author":"Merlin","year":"2012","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.blre.2026.101433_bb0155","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00277-023-05144-2","article-title":"Neonatal hematological parameters: the translational aspect of developmental hematopoiesis","volume":"102","author":"Sokou","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2026.101433_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101157","article-title":"Contemporary tools for evaluation of hemostasis in neonates. Where are we and where are we headed?","volume":"64","author":"Sokou","year":"2024","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0961203314560207","article-title":"Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?","volume":"24","author":"De Carolis","year":"2015","journal-title":"Lupus"},{"issue":"24","key":"10.1016\/j.blre.2026.101433_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249551","article-title":"Genetic factors in antiphospholipid syndrome: preliminary experience with whole exome sequencing","volume":"21","author":"Barinotti","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.blre.2026.101433_bb0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1568-9972(03)00068-5","article-title":"HLA class II alleles and genetic predisposition to the antiphospholipid syndrome","volume":"2","author":"Domenico Sebastiani","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.blre.2026.101433_bb0180","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-0043-1777070","article-title":"Bleeding scoring systems in neonates: a systematic review","volume":"50","author":"Sokou","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.blre.2026.101433_bb0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0040-1715832","article-title":"A risk score for predicting the incidence of hemorrhage in critically ill neonates: development and validation study","volume":"121","author":"Sokou","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101433_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thromres.2020.05.028","article-title":"ROTEM diagnostic capacity for measuring fibrinolysis in neonatal sepsis","volume":"192","author":"Lampridou","year":"2020","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0195","article-title":"Thromboelastometry-based profiling of haemostatic alterations in neonatal sepsis by causative pathogens","volume":"14","author":"Sokou","year":"2025","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2026-002013","article-title":"Antiphospholipid syndrome in the paediatric population: performance of ACR-EULAR classification criteria in a controlled cohort","volume":"13","author":"Niznik","year":"2026","journal-title":"Lupus Sci Med"},{"issue":"5","key":"10.1016\/j.blre.2026.101433_bb0205","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MOH.0000000000000523","article-title":"Antiphospholipid syndrome in pediatric patients","volume":"26","author":"Tarango","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/BOR.0000000000001083","article-title":"Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in children","volume":"37","author":"Lewis","year":"2025","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11926-020-0887-9","article-title":"Pediatric APS: state of the art","volume":"22","author":"Soybilgic","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"10.1016\/j.blre.2026.101433_bb0220","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/0961203320947154","article-title":"APS pregnancy - the offspring","volume":"29","author":"Bitsadze","year":"2020","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.blre.2026.101433_bb0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite Antiphospholipid Syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.blre.2026.101433_bb0230","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1177\/09612033251361040","article-title":"Primary antiphospholipid syndrome in pediatrics: new criteria, new opportunities","volume":"34","author":"Torres Jimenez","year":"2025","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.blre.2026.101433_bb0235","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2665-9913(24)00096-1","article-title":"The outcomes of children born to mothers with autoimmune rheumatic diseases","volume":"6","author":"Andreoli","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"10.1016\/j.blre.2026.101433_bb0240","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/09612033211021488","article-title":"Antiphospholipid antibodies and cerebrovascular thrombosis in the pediatric population: few answers to many questions","volume":"30","author":"Hasbani","year":"2021","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12884-025-07471-w","article-title":"Antiphospholipid syndrome in pregnancy: a comprehensive literature review","volume":"25","author":"Murvai","year":"2025","journal-title":"BMC Preg Childbirth"},{"issue":"7","key":"10.1016\/j.blre.2026.101433_bb0250","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"21","key":"10.1016\/j.blre.2026.101433_bb0255","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and Management of the Antiphospholipid Syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101433_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726820","article-title":"Antiphospholipid antibody assays in 2021: looking for a predictive value in addition to a diagnostic one","volume":"12","author":"Meroni","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.blre.2026.101433_bb0265","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1016\/S2665-9913(25)00094-3","article-title":"Towards precision medicine in antiphospholipid syndrome","volume":"7","author":"Lopez-Pedrera","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"13","key":"10.1016\/j.blre.2026.101433_bb0270","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/09612033251386089","article-title":"Neonatal ischemic stroke potentially associated with transplacental passage of maternal anti-cardiolipin immunoglobulin G antibodies: A case report","volume":"34","author":"Oiwa","year":"2025","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0275","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3324\/haematol.2019.221945","article-title":"Seronegative antiphospholipid syndrome: refining the value of \u201cnon-criteria\u201d antibodies for diagnosis and clinical management","volume":"105","author":"Pignatelli","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-021-02702-9","article-title":"The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study","volume":"24","author":"da Rosa","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0285","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/cei\/uxae079","article-title":"Antibody profiles in the mosaic of \u2018seronegative\u2019 APS syndrome","volume":"218","author":"Truglia","year":"2024","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.blre.2026.101433_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012185","article-title":"Heparin for the treatment of thrombosis in neonates","volume":"11","author":"Romantsik","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0295","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1161\/STR.0000000000000183","article-title":"Management of stroke in neonates and children: a scientific statement from the American Heart Association\/American Stroke Association","volume":"50","author":"Ferriero","year":"2019","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.blre.2026.101433_bb0300","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MBC.0000000000001052","article-title":"How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice","volume":"32","author":"Ting","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"10.1016\/j.blre.2026.101433_bb0305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/MBC.0000000000000469","article-title":"How to use unfractionated heparin to treat neonatal thrombosis in clinical practice","volume":"27","author":"Bhatt","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0310","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjh.13301","article-title":"Neonatal haemostasis and the management of neonatal thrombosis","volume":"169","author":"Will","year":"2015","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.blre.2026.101433_bb0315","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.blre.2026.101433_bb0320","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/jth.15144","article-title":"Thrombosis in infants in the neonatal intensive care unit: analysis of a large national database","volume":"19","author":"Robinson","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2026.101433_bb0325","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jtha.2022.11.044","article-title":"NEOnatal Central-venous Line Observational study on Thrombosis (NEOCLOT): evaluation of a national guideline on management of neonatal catheter-related venous thrombosis","volume":"21","author":"van Ommen","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101433_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109098","article-title":"Short term outcome of neonatal venous thromboembolism in anticoagulated versus observed patients","volume":"241","author":"Beg","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101433_bb0335","series-title":"GeneReviews(\u00ae)","article-title":"Factor V Leiden Thrombophilia","author":"Pastori","year":"1993"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010668","article-title":"Catastrophic antiphospholipid syndrome","volume":"25","author":"Bitsadze","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.blre.2026.101433_bb0345","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tmrv.2022.09.002","article-title":"Emerging therapies in antiphospholipid syndrome","volume":"36","author":"Hubben","year":"2022","journal-title":"Transfus Med Rev"},{"issue":"18","key":"10.1016\/j.blre.2026.101433_bb0350","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.blre.2026.101433_bb0355","article-title":"Transient antiphospholipid syndrome associated with primary cytomegalovirus infection: a case report and literature review","volume":"2014","author":"Nakayama","year":"2014","journal-title":"Case Rep Rheumatol"},{"issue":"4","key":"10.1016\/j.blre.2026.101433_bb0360","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2007.10.001","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and infections","volume":"7","author":"S\u00e8ne","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.blre.2026.101433_bb0365","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jacc.2023.10.038","article-title":"When direct oral anticoagulants should not be standard treatment: JACC state-of-the-art review","volume":"83","author":"Bejjani","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.blre.2026.101433_bb0370","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct Oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: Meta-analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.blre.2026.101433_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15166221","article-title":"Neonatal thromboembolic disease: clinical spectrum and emerging evidence for diagnostic and therapeutic strategies addressing unmet needs","volume":"15","author":"Sokou","year":"2026","journal-title":"J Clin Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2600072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2600072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:29:00Z","timestamp":1789270140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X2600072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":75,"alternative-id":["S0268960X2600072X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101433","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal antiphospholipid syndrome\u2013associated thrombosis: Diagnostic pitfalls and therapeutic frontiers","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101433"}}